Global Vagus Nerve Stimulators Market to grow at a CAGR of 9.06% by 2030, Evaluates DelveInsight | LivaNova, Soterix Medical Inc, MicroTransponder Inc, Parasym Ltd, electroCore, tVNS Technologies GmbH

According to DelveInsight's analysis, the vagus nerve stimulators market is experiencing notable growth, primarily fueled by the increasing prevalence of neurological conditions like epilepsy and migraine, which have shown positive responses to VNS therapy. The therapy's rising adoption as an alternative or complementary approach in cases of drug resistance is further contributing to its demand. Additionally, expanding research into VNS applications for conditions beyond current approvals-such as tinnitus and chronic pain-and ongoing technological advancements, including the introduction of non-invasive VNS devices, are expected to significantly propel market growth from 2024 to 2030.

DelveInsight's "Vagus Nerve Stimulators Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Vagus Nerve Stimulators companies actively working in the market.

To know more about why North America is leading the market growth in the Vagus Nerve Stimulators market, get a snapshot of the report Vagus Nerve Stimulators Market Trends
https://www.delveinsight.com/sample-request/vagus-nerve-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Vagus Nerve Stimulators Overview
Vagus Nerve Stimulators (VNS) are medical devices designed to deliver electrical impulses to the vagus nerve, which plays a key role in regulating various bodily functions. These stimulators are commonly used to treat neurological conditions such as epilepsy and treatment-resistant depression. The device is typically implanted under the skin in the chest, with a wire connected to the vagus nerve in the neck. Newer, non-invasive versions stimulate the nerve through the skin. VNS therapy helps modulate brain activity and has shown promise in other conditions like migraines, tinnitus, and chronic pain.

DelveInsight Analysis: The global vagus nerve stimulators market reached a valuation of USD 426.22 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.06% from 2024 to 2030, reaching approximately USD 717.17 million by the end of the forecast period.

Vagus Nerve Stimulators Market Insights
Geographically, North America is projected to hold the largest share of the vagus nerve stimulators market. This growth is primarily driven by the region's high rates of epilepsy and depression, increasing disposable income, and substantial investments and strategic partnerships by major industry players. Additionally, the supportive regulatory framework in North America further strengthens its leading position in the global VNS market.

To read more about the latest highlights related to Vagus Nerve Stimulators, get a snapshot of the key highlights entailed in the Vagus Nerve Stimulators
https://www.delveinsight.com/report-store/vagus-nerve-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Vagus Nerve Stimulators Market Report
• In August 2021, The US Food and Drug Administration granted approval for the MicroTransponder Vivistim Paired VNS System, a unique, drug-free rehabilitation device designed to address moderate to severe motor impairments in the upper limbs caused by chronic ischemic stroke.
• In March 2020, LivaNova obtained CE Mark approval for its Vagus Nerve Stimulation Therapy® (VNS Therapy) System, SymmetryTM, intended for the treatment of hard-to-manage depression.
• Thus, owing to such developments in the market, rapid growth will be observed in the Vagus Nerve Stimulators market during the forecast period

Key Players in the Vagus Nerve Stimulators Market
Some of the key market players operating in the Vagus Nerve Stimulators market include- LivaNova, Soterix Medical Inc, MicroTransponder Inc, Parasym Ltd, electroCore, tVNS Technologies GmbH, and others.

Which MedTech key players in the Vagus Nerve Stimulators market are set to emerge as the trendsetter explore @ Key Vagus Nerve Stimulators Companies
https://www.delveinsight.com/sample-request/vagus-nerve-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Vagus Nerve Stimulators Market Landscape
The demand for vagus nerve stimulators is rising due to several contributing factors, with one of the primary drivers being the growing incidence of neurological disorders. According to the World Health Organization (WHO) data from 2023, more than 50 million people worldwide are affected by epilepsy. Additionally, the organization noted that the prevalence of active epilepsy-characterized by ongoing seizures or the need for continuous treatment-ranges between 4 and 10 individuals per 1,000 in the general population.
Furthermore, as increasing positive outcomes are being observed with VNS therapy, research is expanding into new therapeutic areas, potentially broadening the future scope of vagus nerve stimulation. For example, ongoing studies are investigating its effects on conditions such as tinnitus, irritable bowel syndrome, and chronic pain, among others. These efforts could open up significant growth avenues for the VNS market in the near future. However, challenges such as procedure-related risks and the high cost of devices may act as limiting factors to the market's expansion. As a result, these factors are expected to contribute to the continued expansion of the Vagus Nerve Stimulators market from 2024 to 2030.

Scope of the Vagus Nerve Stimulators Market Report
• Coverage: Global
• Study Period: 2021-2030
• Vagus Nerve Stimulators Market Segmentation By Product Type: (Invasive VNS Devices and Non-Invasive VNS Devices
• Vagus Nerve Stimulators Market Segmentation By Application Type: Migraine, Epilepsy, Depression, and Others
• Vagus Nerve Stimulators Market Segmentation By End-User: Migraine, Epilepsy, Depression, and Others
• Vagus Nerve Stimulators Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Vagus Nerve Stimulators Companies: LivaNova, Soterix Medical Inc, MicroTransponder Inc, Parasym Ltd, electroCore, tVNS Technologies GmbH, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Vagus Nerve Stimulators market will grow by 2030? Click to get a snapshot of the Vagus Nerve Stimulators Market Analysis
https://www.delveinsight.com/sample-request/vagus-nerve-stimulator-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Vagus Nerve Stimulators Market Report Introduction
2 Vagus Nerve Stimulators Market Executive summary
3 Regulatory and Patent Analysis
4 Vagus Nerve Stimulators Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Vagus Nerve Stimulators Market
7 Vagus Nerve Stimulators Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11 Vagus Nerve Stimulators Market Drivers
12 Vagus Nerve Stimulators Market Barriers
13 About DelveInsight

Latest Reports by DelveInsight
• Sglt2 Inhibitors Market: https://www.delveinsight.com/report-store/sglt2-inhibitors-market
• Electroencephelographs Pipeline Insight: https://www.delveinsight.com/report-store/epilepsy-pipeline-insight
• Fabry Disease Market: https://www.delveinsight.com/report-store/fabry-disease-market
• Dental Implants And Prosthesis Market: https://www.delveinsight.com/report-store/dental-implants-and-prosthesis-market
• Peritoneal Dialysis Equipment Market: https://www.delveinsight.com/report-store/peritoneal-dialysis-equipment-market
• Drug-eluting Stents Market Market: https://www.delveinsight.com/report-store/drug-eluting-stents-market
• Sinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
Connect With Us at:
LinkedIn | Facebook | Twitter

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.